Nicolas Lecrenier

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Venues

Human vaccines & immunotherapeutics

Dermatology and therapy

Expert review of vaccines

Drug safety

GlaxoSmithKline Plc

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GlaxoSmithKline Plc Jun 01 2001

Belgium

Global Medical Affairs lead :: Medical Affairs

Publications

V Ramasubramanian, Agam Vora, Youness Lagoubi, Nicolas Lecrenier, Yashpal Chugh
Proceedings of the expert consensus group meeting on herpes zoster disease burden and prevention in India: An opinion paper. Human vaccines & immunotherapeutics (2023)
Agnes Mwakingwe-Omari, Nicolas Lecrenier, Abdi Naficy, Desmond Curran, Inga Posiuniene
Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies. Human vaccines & immunotherapeutics 19 (3) (2023)
Desmond Curran, Elizabeth M La, Ahmed Ehab Salem, David Singer, Nicolas Lecrenier, Sara Poston
Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United States. Human vaccines & immunotherapeutics 18 (1) (2022)
Desmond Curran, Sean Matthews, Céline Boutry, Nicolas Lecrenier, Anthony L Cunningham, Kenneth E Schmader
Natural History of Herpes Zoster in the Placebo Groups of Three Randomized Phase III Clinical Trials. Infectious diseases and therapy 11 (6) (2022)
Paola Pirrotta, Fernanda Tavares-da-Silva, Maribel Co, Nicolas Lecrenier, Caroline Hervé, Jens-Ulrich Stegmann
An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine. Drug safety 44 (12) (2021)
Javier Diez-Domingo, Raunak Parikh, Amit B Bhavsar, Elisa Cisneros, Natalia McCormick, Nicolas Lecrenier
Can COVID-19 Increase the Risk of Herpes Zoster? A Narrative Review. Dermatology and therapy 11 (4) (2021)
Nicolas Lecrenier, Alen Marijam, Jan Olbrecht, Bruce A Mungall, Javier Nieto Guevara, Bruce A Mungall
Ten years of experience with the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (Synflorix) in children. Expert review of vaccines 19 (3) (2020)

Nicolas Lecrenier.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nicolas Lecrenier